Biotricity, Inc. (OTCQB: BTCY) was delisted from The Nasdaq Stock Market, with its securities suspended on August 5, 2024. The company's common stock had not traded on Nasdaq since that date.
This delisting means Biotricity's shares transitioned to trading on the OTCQB market. Such a move typically impacts a company's visibility and can affect its ability to attract institutional investors.
The change in listing venue reflects a significant shift in the company's market presence. It requires investors to adjust to trading on a different exchange with potentially different liquidity characteristics.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.